Gene expression-based biological test for major depressive disorder: an advanced study

Código QR

Gene expression-based biological test for major depressive disorder: an advanced study

Shin-ya Watanabe,1 Shusuke Numata,1 Jun-ichi Iga,2 Makoto Kinoshita,1 Hidehiro Umehara,1 Kazuo Ishii,3 Tetsuro Ohmori1 1Department of Psychiatry, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, 2Department of Neuropsychiatry, Molecules and Function, Ehime Universi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	depressive disorder biomarker gene expression schizophrenia bipolar disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/24dca6390f384e50bedaf99f7b4963d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

When should a psychiatrist remember to test homocysteine levels? - a literature review
por: Nowak Katarzyna, et al.
Publicado: (2021)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Elevated peripheral blood glutamate levels in major depressive disorder
por: Inoshita M, et al.
Publicado: (2018)

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
por: Bracha Erlanger Avigdor, et al.
Publicado: (2021)

The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis
por: Mingyue Fan, et al.
Publicado: (2021)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
por: Puspitasari IM, et al.
Publicado: (2020)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Enfermedades afectivas y actividad solar: Seguimiento a 16 años
por: IVANOVIC-ZUVIC,FERNANDO, et al.
Publicado: (2010)

CLINICAL FEATURES OF SOMATIZED DEPRESSION FOR VARIOUS COURSE OF AFFECTIVE DISEASE ACCORDING TO GENDER OF THE PATIENT
por: V. S. Sobennikov, et al.
Publicado: (2016)

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
por: Grambal A, et al.
Publicado: (2016)

Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
por: Xinqiao Zhang, et al.
Publicado: (2021)

Association of carbohydrate and fatty acid intake with anthropometric parameters in subjects with schizophrenia and bipolar disorders
por: Santillana T,Natalia, et al.
Publicado: (2016)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo Q, et al.
Publicado: (2019)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Reduced plasma orexin-A levels in patients with bipolar disorder
por: Tsuchimine S, et al.
Publicado: (2019)

A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
por: Kopelowicz A, et al.
Publicado: (2017)

CLINICAL COURSE AND DIAGNOSTICS OF NON-PSYCHOTIC AFFECTIVE DISORDERS BASED ON LONG-TERM CATAMNESIS
por: V. S. Sobennikov, et al.
Publicado: (2015)

Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes <i>BSN</i> and <i>PCLO</i> in Schizophrenia and Bipolar Disorder
por: Chia-Hsiang Chen, et al.
Publicado: (2021)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin N, et al.
Publicado: (2020)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020)

Editorial: The Role of Resilience and the Interplay Between Genetics and Environment in Bipolar Disorder
por: Bianca Pfaffenseller, et al.
Publicado: (2021)

Atypical depression: current perspectives
por: Łojko D, et al.
Publicado: (2017)

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
por: Miguel A. Ortega, et al.
Publicado: (2021)

Effect of medication therapy combined with transcranial direct current stimulation on depression and response inhibition of patients with bipolar disorder type I: a clinical trial
por: Parnaz Mardani, et al.
Publicado: (2021)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

Weighted Gene Coexpression Network Analysis Identifies Specific Modules and Hub Genes Related to Major Depression
por: Zhang G, et al.
Publicado: (2020)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen JJ, et al.
Publicado: (2018)

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study
por: Van der Watt ASJ, et al.
Publicado: (2018)

Effective Connectivity between Major Nodes of the Limbic System, Salience and Frontoparietal Networks Differentiates Schizophrenia and Mood Disorders from Healthy Controls
por: Sevdalina Kandilarova, et al.
Publicado: (2021)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
por: Bai S, et al.
Publicado: (2021)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff SN
Publicado: (2019)

Pattern of burden on the family of patients with schizophrenia and bipolar disorder: A comparative study
por: Khurshida Khatoon, et al.
Publicado: (2021)

Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort
por: Esteban Munoz Musat, et al.
Publicado: (2021)

Gene–Environment Interactions in Major Mental Disorders in the Czech Republic
por: Latalova K, et al.
Publicado: (2020)

Evaluación de la calidad de vida de pacientes bipolares chilenos: propiedades psicométricas y utilidad diagnóstica de la versión chilena del cuestionario Quality of Life Bipolar Disorder (QoL.BD-CL)
por: Morgado,Carolina, et al.
Publicado: (2015)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska A, et al.
Publicado: (2021)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová M, et al.
Publicado: (2019)

Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression
por: Khulekani Mncube, et al.
Publicado: (2021)